Jian-Xiang Wang (Jianxiang Wang, Jiangxiang Wang)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 53

Top Venues

Journal for immunotherapy of cancer

Leukemia

British journal of haematology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Wei Liu, Wei Liu, Hesong Zou, Lianting Chen, Wenyang Huang, Rui Lv, Yan Xu, Huimin Liu, Yin Shi, Kefei Wang, Yi Wang, Wenjie Xiong, Shuhui Deng, Shuhua Yi, Weiwei Sui, Guangxin Peng, Yueshen Ma, Huijun Wang, Lulu Lv, Jian-Xiang Wang, Jun Wei, Lugui Qiu, Wenting Zheng, Dehui Zou
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. Journal for immunotherapy of cancer 12 (4) (2024)
Wei Liu, Hesong Zou, Lianting Chen, Wenyang Huang, Rui Lv, Yan Xu, Huimin Liu, Yin Shi, Kefei Wang, Yi Wang, Wenjie Xiong, Shuhui Deng, Shuhua Yi, Weiwei Sui, Guangxin Peng, Yueshen Ma, Huijun Wang, Lulu Lv, Jian-Xiang Wang, Jun Wei, Lugui Qiu, Wenting Zheng, Dehui Zou
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. Journal for immunotherapy of cancer 12 (4) (2024)
Benfa Gong, Li-Jen Cheng, Christopher H Young, Prabhuram Krishnan, Ying Wang, Hui Wei, Chunlin Zhou, Shuning Wei, Yan Li, Qiuyun Fang, Jia Zhong, Eric Q Wu, Yingchang Mi, Jian-Xiang Wang
Treatment Patterns and FLT3 Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study. Therapeutics and clinical risk management 20 (2024)
Benfa Gong, Li-Jen Cheng, Christopher H Young, Prabhuram Krishnan, Ying Wang, Hui Wei, Chunlin Zhou, Shuning Wei, Yan Li, Qiuyun Fang, Jia Zhong, Eric Q Wu, Yingchang Mi, Jian-Xiang Wang
Treatment Patterns and FLT3 Mutation Testing Among Patients with Acute Myeloid Leukemia in China: A Retrospective Observational Study. Therapeutics and clinical risk management 20 (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Hesong Zou, Wei Liu, Xiaojuan Wang, Yi Wang, Chunyang Wang, Chen Qiu, Huimin Liu, Dandan Shan, Ting Xie, Wenyang Huang, Weiwei Sui, Shuhua Yi, Gang An, Yan Xu, Tonghui Ma, Jian-Xiang Wang, Lugui Qiu, Dehui Zou
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. Journal for immunotherapy of cancer 12 (3) (2024)
Hesong Zou, Wei Liu, Xiaojuan Wang, Yi Wang, Chunyang Wang, Chen Qiu, Huimin Liu, Dandan Shan, Ting Xie, Wenyang Huang, Weiwei Sui, Shuhua Yi, Gang An, Yan Xu, Tonghui Ma, Jian-Xiang Wang, Lugui Qiu, Dehui Zou
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. Journal for immunotherapy of cancer 12 (3) (2024)
Xiaoyu Liu, Yu Liu, Qing Rao, Yihan Mei, Haiyan Xing, Runxia Gu, Junli Mou, Manling Chen, Fan Ding, Wanqing Xie, Kejing Tang, Zheng Tian, Min Wang, Shaowei Qiu, Jian-Xiang Wang
Targeting Fatty Acid Metabolism Abrogates the Differentiation Blockade in Pre-leukemic Cells. Cancer research (2024)
Hesong Zou, Wei Liu, Xiaojuan Wang, Yi Wang, Chunyang Wang, Chen Qiu, Huimin Liu, Dandan Shan, Ting Xie, Wenyang Huang, Weiwei Sui, Shuhua Yi, Gang An, Yan Xu, Tonghui Ma, Jian-Xiang Wang, Lugui Qiu, Dehui Zou
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. Journal for immunotherapy of cancer 12 (3) (2024)
Wei Liu, Hesong Zou, Lianting Chen, Wenyang Huang, Rui Lv, Yan Xu, Huimin Liu, Yin Shi, Kefei Wang, Yi Wang, Wenjie Xiong, Shuhui Deng, Shuhua Yi, Weiwei Sui, Guangxin Peng, Yueshen Ma, Huijun Wang, Lulu Lv, Jian-Xiang Wang, Jun Wei, Lugui Qiu, Wenting Zheng, Dehui Zou
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. Journal for immunotherapy of cancer 12 (4) (2024)
Huan Li, Zhijie Cao, Yiming Liu, Zhenya Xue, Yishuang Li, Haiyan Xing, Yingxi Xu, Runxia Gu, Shaowei Qiu, Hui Wei, Min Wang, Qing Rao, Jian-Xiang Wang
Slow-replicating leukemia cells represent a leukemia stem cell population with high cell-surface CD74 expression. Molecular oncology (2024)
Wei Liu, Hesong Zou, Lianting Chen, Wenyang Huang, Rui Lv, Yan Xu, Huimin Liu, Yin Shi, Kefei Wang, Yi Wang, Wenjie Xiong, Shuhui Deng, Shuhua Yi, Weiwei Sui, Guangxin Peng, Yueshen Ma, Huijun Wang, Lulu Lv, Jian-Xiang Wang, Jun Wei, Lugui Qiu, Wenting Zheng, Dehui Zou
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. Journal for immunotherapy of cancer 12 (4) (2024)
Yu Liu, Wenbing Liu, Anli Lai, Yihan Mei, Ying Wang, Hui Wei, Qing Rao, Runxia Gu, Yingchang Mi, Min Wang, Jian-Xiang Wang, Shaowei Qiu
Multiomic analysis identifies a high-risk subgroup that predicts poor prognosis in t(8;21) acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology (2024)
Hesong Zou, Wei Liu, Xiaojuan Wang, Yi Wang, Chunyang Wang, Chen Qiu, Huimin Liu, Dandan Shan, Ting Xie, Wenyang Huang, Weiwei Sui, Shuhua Yi, Gang An, Yan Xu, Tonghui Ma, Jian-Xiang Wang, Lugui Qiu, Dehui Zou
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. Journal for immunotherapy of cancer 12 (3) (2024)
Keith W Pratz, Brian A Jonas, Vinod A Pullarkat, Michael J Thirman, Jacqueline S Garcia, Hartmut Döhner, Christian Recher, Walter Fiedler, Kazuhito Yamamoto, Jian-Xiang Wang, Sung-Soo Yoon, Ofir Wolach, Su-Peng Yeh, Brian Leber, Jordi Esteve, Jiri Mayer, Kimmo Porkka, Árpád Illés, Roberto M Lemoli, Mehmet Turgut, Grace Ku, Catherine Miller, Ying Zhou, Meng Zhang, Brenda J Chyla, Jalaja Potluri, Courtney D D DiNardo
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia. American journal of hematology 99 (4) (2024)
Jian-Xiang Wang, Bin Jiang, Jian Li, Ligen Liu, Xin Du, Hao Jiang, Jian-da Hu, Menghe Yuan, Taishi Sakatani, Takeshi Kadokura, Masato Takeuchi, Masanori Kosako, Xiao Ma, Larisa Girshova, Jerome Tan, Sergey Bondarenko, Lily Wong Lee Lee, Archrob Khuhapinant, Elena Martynova, Nahla Hasabou
Phase 3 study of gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia. Leukemia (2024)
Hartmut Döhner, Courtney D D DiNardo, Andrew H Wei, Bob Löwenberg, Frederick Appelbaum, Charles F Craddock, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Lucy A Godley, Robert P Hasserjian, Richard A Larson, Ross L Levine, Yasushi Miyazaki, Dietger Niederwieser, Gert J Ossenkoppele, Christoph Röllig, Sierra Jorge, Eytan M Stein, Martin S Tallman, Hwei-Fang Tien, Jian-Xiang Wang, Agnieszka Świątek
Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood (2024)
Wei Liu, Hesong Zou, Lianting Chen, Wenyang Huang, Rui Lv, Yan Xu, Huimin Liu, Yin Shi, Kefei Wang, Yi Wang, Wenjie Xiong, Shuhui Deng, Shuhua Yi, Weiwei Sui, Guangxin Peng, Yueshen Ma, Huijun Wang, Lulu Lv, Jian-Xiang Wang, Jun Wei, Lugui Qiu, Wenting Zheng, Dehui Zou
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. Journal for immunotherapy of cancer 12 (4) (2024)
Wei Liu, Wei Liu, Hesong Zou, Lianting Chen, Wenyang Huang, Rui Lv, Yan Xu, Huimin Liu, Yin Shi, Kefei Wang, Yi Wang, Wenjie Xiong, Shuhui Deng, Shuhua Yi, Weiwei Sui, Guangxin Peng, Yueshen Ma, Huijun Wang, Lulu Lv, Jian-Xiang Wang, Jun Wei, Lugui Qiu, Wenting Zheng, Dehui Zou
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma. Journal for immunotherapy of cancer 12 (4) (2024)
Zhe Wang, Ting Liu, Wenbing Liu, Xin Gao, Li Wan, Shaowei Qiu, Yang Song, Runxia Gu, Zheng Tian, Min Wang, Jian-Xiang Wang, Yingchang Mi, Shuning Wei
A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects. Cancer gene therapy (2023)
Zhenzhen Wang, Yang Lu, Yu Liu, Junli Mou, Xiaoyu Liu, Manling Chen, Ying Wang, Yingxi Xu, Qing Rao, Haiyan Xing, Kejing Tang, Zheng Tian, Bing Wang, Wei Qi, Min Wang, Shaowei Qiu, Dongsheng Xiong, Jian-Xiang Wang
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity. Cancer communications (London, England) (2023)
Mikkael A Sekeres, Pau Montesinos, Jan Novak, Jian-Xiang Wang, Deepa Jeyakumar, Benjamin K Tomlinson, Jiri Mayer, Erin Jou, Tadeusz Robak, David C Taussig, Hervé Dombret, Akil A Merchant, Naveed Shaik, Thomas O'Brien, Whijae Roh, Xueli Liu, Wendy Ma, Christine G DiRienzo, Geoffrey Chan, Jorge E Cortes
Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia (2023)
Min Yu, Qian Zhang, Fancong Kong, Ling Qi, Yafang Pu, Lugui Qiu, Jian-Xiang Wang, Fei Li
Efficacy and Safety of Dual-Targeting Chimeric Antigen Receptor-T Therapy for Relapsed or Refractory B Cell Lymphoid Malignancies: A Systematic Review and Meta-Analysis. Human gene therapy 34 (5-6) (2023)
Qiujin Shen, Yahui Feng, Xiaowen Gong, Yujiao Jia, Qingyan Gao, Xiaokang Jiao, Saibing Qi, Xueou Liu, Hui Wei, Bingqing Huang, Ningning Zhao, Xiaoqiang Song, Yueshen Ma, Shihao Liang, Donglei Zhang, Li Qin, Ying Wang, Shiqiang Qu, Yao Zou, Yumei Chen, Ye Guo, Shuhua Yi, Gang An, Zengtao Jiao, Song Zhang, Linfeng Li, Jun Yan, Huijun Wang, Zhen Song, Yingchang Mi, Lugui Qiu, Xiaofan Zhu, Jian-Xiang Wang, Zhijian Xiao, Junren Chen
A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms. Cancer research communications 2 (4) (2022)
Shuning Wei, Runxia Gu, Yingchang Mi, Zhangsong Yan, Yimin Hu, Dong Lin, Kaiqi Liu, Chunlin Zhou, Guangji Zhang, Ying Wang, Jian-Xiang Wang, Yingchang Mi
Early-salvage therapy with venetoclax-based regimens for induction failure and poor early response acute lymphoblastic leukaemia: A retrospective case series of 13 patients. British journal of haematology 199 (5) (2022)
Hartmut Döhner, Andrew H Wei, Frederick R Appelbaum, Charles Craddock, Courtney D D DiNardo, Hervé Dombret, Benjamin L Ebert, Pierre Fenaux, Lucy A Godley, Robert P Hasserjian, Richard A Larson, Ross L Levine, Yasushi Miyazaki, Dietger Niederwieser, Gert Ossenkoppele, Christoph Röllig, Sierra Jorge, Eytan M Stein, Martin S Tallman, Hwei-Fang Tien, Jian-Xiang Wang, Agnieszka Świątek, Bob Löwenberg
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood 140 (12) (2022)
Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Inho Kim, Jan Novak, Rebecca Champion, Walter Fiedler, Maria Pagoni, Julie Bergeron, Stephen Ting, JingZhou Hou, Achilles Anagnostopoulos, Andrew McDonald, Vidhya Murthy, Takahiro Yamauchi, Jian-Xiang Wang, Qi Jiang, Yan Sun, Brenda Chyla, Wellington L Mendes, Courtney D D DiNardo
Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Blood (2022)
Nianci Chen, Yingxi Xu, Junli Mou, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Min Wang, Jian-Xiang Wang
Correction: Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood cancer journal 12 (3) (2022)
Jun Wang, Yuting Yan, Wenjie Xiong, Ge Song, Yi Wang, Jiawei Zhao, Yujiao Jia, Chengwen Li, Zhen Yu, Ying Yu, Jiawen Chen, Yang Jiao, Tingyu Wang, Rui Lv, Qinghua Li, Yueshen Ma, Wei Liu, Dehui Zou, Gang An, Qi Sun, Huijun Wang, Zhijian Xiao, Jian-Xiang Wang, Lugui Qiu, Shuhua Yi
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM. Blood advances 6 (13) (2022)
Yu Zhang, Saisai Li, Ying Wang, Yang Lu, Yingxi Xu, Qing Rao, Huijun Wang, Haiyan Xing, Zheng Tian, Kejing Tang, Lulu Lv, Min Wang, Jian-Xiang Wang
A novel and efficient CD22 CAR-T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR-T treatment as a sequential therapy. Experimental hematology & oncology 11 (1) (2022)
Hui Wei, Chunlin Zhou, Bingcheng Liu, Dong Lin, Yan Li, Shuning Wei, Benfa Gong, Guangji Zhang, Kaiqi Liu, Xiaoyuan Gong, Qiuyun Fang, Yuntao Liu, Shaowei Qiu, Runxia Gu, Zhen Song, Jiayuan Chen, Miao Yang, Junping Zhang, Jingjing Jin, Ying Wang, Yingchang Mi, Jian-Xiang Wang
The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm). British journal of haematology 197 (4) (2022)
Qiujin Shen, Yahui Feng, Xiaowen Gong, Yujiao Jia, Qingyan Gao, Xiaokang Jiao, Saibing Qi, Xueou Liu, Hui Wei, Bingqing Huang, Ningning Zhao, Xiaoqiang Song, Yueshen Ma, Shihao Liang, Donglei Zhang, Li Qin, Ying Wang, Shiqiang Qu, Yao Zou, Yumei Chen, Ye Guo, Shuhua Yi, Gang An, Zengtao Jiao, Song Zhang, Linfeng Li, Jun Yan, Huijun Wang, Zhen Song, Yingchang Mi, Lugui Qiu, Xiaofan Zhu, Jian-Xiang Wang, Zhijian Xiao, Junren Chen
A Phenogenetic Axis that Modulates Clinical Manifestation and Predicts Treatment Outcome in Primary Myeloid Neoplasms. Cancer research communications 2 (4) (2022)
Zhe Liu, Xuanjia Dong, Zhijie Cao, Shaowei Qiu, Yihui Li, Mengjun Zhong, Zhenya Xue, Yingxi Xu, Haiyan Xing, Kejing Tang, Zheng Tian, Min Wang, Qing Rao, Jian-Xiang Wang
Mutant U2AF1-induced differential alternative splicing causes an oxidative stress in bone marrow stromal cells. Experimental biology and medicine (Maywood, N.J.) 246 (15) (2021)
Rui Lv, Tingyu Wang, Yi Wang, Wenjie Xiong, Huijun Wang, Yuting Yan, Qi Wang, Wei Liu, Gang An, Wenyang Huang, Weiwei Sui, Yan Xu, Dehui Zou, Jian-Xiang Wang, Lugui Qiu, Shuhua Yi
Undetectable minimal residual disease is an independent prognostic factor in splenic marginal zone lymphoma. British journal of haematology 194 (5) (2021)
Nianci Chen, Yingxi Xu, Junli Mou, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Min Wang, Jian-Xiang Wang
Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells. Blood cancer journal 11 (8) (2021)
Jun Shen, Yingxi Xu, Shuo Zhang, Shuzhen Lyu, Yingying Huo, Yaoyao Zhu, Kejing Tang, Junli Mou, Xinjie Li, Dixie L Hoyle, Min Wang, Jian-Xiang Wang, Xin Li, Zack Z Wang, Tao Cheng
Single-cell transcriptome of early hematopoiesis guides arterial endothelial-enhanced functional T cell generation from human PSCs. Science advances 7 (36) (2021)
Shuhua Yi, Yuting Yan, Meiling Jin, Wenjie Xiong, Zhen Yu, Ying Yu, Rui Cui, Jun Wang, Yi Wang, Yani Lin, Yujiao Jia, Donglei Zhang, Tingyu Wang, Rui Lv, Wei Liu, Weiwei Sui, Wenyang Huang, Mingwei Fu, Yan Xu, Shuhui Deng, Gang An, Dehui Zou, Zengjun Li, Jun Shi, Zhijian Xiao, Jian-Xiang Wang, Tao Cheng, Robert Peter Gale, Lili Wang, Lugui Qiu
High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia. Leukemia 35 (8) (2021)
Yingxi Xu, Junli Mou, Ying Wang, Wei Zhou, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Min Wang, Jian-Xiang Wang
Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway. Leukemia (2021)
Shouyun Li, Xue Yang, Shuang Liu, Yirui Chen, Haiyan Xing, Kejing Tang, Zheng Tian, Yingxi Xu, Qing Rao, Min Wang, Jian-Xiang Wang
A novel fusion protein TBLR1-RARα acts as an oncogene to induce murine promyelocytic leukemia: identification and treatment strategies. Cell death & disease 12 (6) (2021)
Li Chen, Hong-Ming Zhu, Yan Li, Qi-Fa Liu, Yu Hu, Jian-Feng Zhou, Jie Jin, Jian-Da Hu, Ting Liu, De-Pei Wu, Jie-Ping Chen, Yong-Rong Lai, Jian-Xiang Wang, Juan Li, Jian-Yong Li, Xin Du, Xin Wang, Ming-Zhen Yang, Jin-Song Yan, Gui-Fang Ouyang, Li Liu, Ming Hou, Xiao-Jun Huang, Xiao-Jing Yan, Dan Xu, Wei-Ming Li, Deng-Ju Li, Yin-Jun Lou, Zheng-Jun Wu, Ting Niu, Ying Wang, Xiao-Yang Li, Jian-Hua You, Hui-Jin Zhao, Yú Chen, Yang Shen, Qiu-Sheng Chen, Yù Chen, Jian Li, Bing-Shun Wang, Wei-Li Zhao, Jian-Qing Mi, Kan-Kan Wang, Jiong Hu, Zhu Chen, Sai-Juan Chen, Jun-Min Li
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial). Proceedings of the National Academy of Sciences of the United States of America 118 (6) (2021)
Yuting Yan, Xiaoqi Qin, Jiahui Liu, Huishou Fan, Wenqiang Yan, Lanting Liu, Chenxing Du, Zhen Yu, Lian Xu, Mu Hao, Shuhui Deng, Weiwei Wei Sui, Rui Lv, Wei Liu, Qi Wang, Dehui Zou, Linping Hu, Jian-Xiang Wang, Yu-Tzu Tai, Kenneth C Anderson, Lei Zhang, Tao Cheng, Anders Zetterberg, Nikhil C Munshi, Lugui Qiu, Gang An
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single cell level by QM-FISH. Blood advances (2021)
Runxia Gu, Jingjing Cao, Shuning Wei, Xiaoyuan Gong, Ying Wang, Yingchang Mi, Junping Zhang, Shaowei Qiu, Qing Rao, Min Wang, Hui Wei, Jian-Xiang Wang
Evaluation of pretreatment telomere length as a prognostic marker in intermediate-risk acute myeloid leukemia. International journal of laboratory hematology 43 (6) (2021)
Li Zhang, Li Meng, Bingcheng Liu, Yanli Zhang, Huanling Zhu, Jiuwei Cui, Aining Sun, Yu Hu, Jie Jin, Hao Jiang, Xi Zhang, Yan Li, Li Liu, Wanggang Zhang, Xiaoli Liu, Jian Gu, Jianhui Qiao, Guifang Ouyang, Xin Liu, Jianmin Luo, Ming Jiang, Xiaobao Xie, Jianyong Li, Chunting Zhao, Mei Zhang, Tonghua Yang, Jian-Xiang Wang
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)
Runxia Gu, Fang Liu, Dehui Zou, Yingxi Xu, Yang Lu, Bingcheng Liu, Wei Liu, Xiaojuan Chen, Kaiqi Liu, Ye Guo, Xiaoyuan Gong, Rui Lv, Xia Chen, Chunlin Zhou, Mengjun Zhong, Huijun Wang, Hui Wei, Yingchang Mi, Lugui Qiu, Lulu Lv, Min Wang, Ying Wang, Xiaofan Zhu, Jian-Xiang Wang
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia. Journal of hematology & oncology 13 (1) (2020)
Anna Turkina, Jian-Xiang Wang, Vikram Mathews, Guray Saydam, Chul Won Jung, Hani Hassan Al Hashmi, Mohamed Yassin, Solenn Le Clanche, Darko Miljkovic, Cassandra Slader, Timothy P Hughes
TARGET: a survey of real-world management of chronic myeloid leukaemia across 33 countries. British journal of haematology 190 (6) (2020)
Jorge E Cortes, Qian Jiang, Jian-Xiang Wang, Jianyu Weng, Huanling Zhu, Xiaoli Liu, Andreas Hochhaus, Dong-Wook Kim, Jerald Radich, Michael Savona, Patricia Martin-Regueira, Oumar Sy, Renuka Gurnani, Giuseppe Saglio
Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study. Leukemia 34 (8) (2020)
Wei Liu, Wenyang Huang, Min Wang, Rui Lv, Jian Li, Ying Wang, Shuhui Deng, Shuhua Yi, Hong Liu, Qing Rao, Yingxi Xu, Lulu Lv, Lugui Qiu, Dehui Zou, Jian-Xiang Wang
Risk of hepatitis B reactivation is controllable in patients with B-cell lymphoma receiving anti-CD19 CAR T cell therapy. British journal of haematology 191 (1) (2020)
Xue-Han Mao, Jun-Ling Zhuang, Duo-Duo Zhao, Xiao-Qing Li, Xin Du, Mu Hao, Yan Xu, Yu-Ting Yan, Jia-Hui Liu, Hui-Shou Fan, Wei-Wei Sui, Shu-Hui Deng, Cheng-Wen Li, Jia-Wei Zhao, Shu-Hua Yi, Chen-Xing Du, De-Hui Zou, Zeng-Jun Li, Yao-Zhong Zhao, Feng-Huang Zhan, Yu-Tzu Tai, Bai-Jun Fang, Yong-Ping Song, Jian-Xiang Wang, Kenneth C Anderson, Lu-Gui Qiu, Gang An
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patients. European journal of haematology 105 (3) (2020)
Yingxi Xu, Qian Liu, Mengjun Zhong, Zhenzhen Wang, Zhaoqi Chen, Yu Zhang, Haiyan Xing, Zheng Tian, Kejing Tang, Xiaolong Liao, Qing Rao, Min Wang, Jian-Xiang Wang
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies. Journal of hematology & oncology 12 (1) (2019)
Damodar Gullipalli, Fengkui Zhang, Sayaka Sato, Yoshiyasu Ueda, Yuko Kimura, Madhu Golla, Takashi Miwa, Jian-Xiang Wang, Wen-Chao Song
Antibody Inhibition of Properdin Prevents Complement-Mediated Intravascular and Extravascular Hemolysis. Journal of immunology (Baltimore, Md. : 1950) 201 (3) (2018)
Huan Li, Na Zhao, Yihui Li, Haiyan Xing, Shuying Chen, Yingxi Xu, Kejing Tang, Zheng Tian, Min Wang, Qing Rao, Jian-Xiang Wang
c-MPL Is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells. Stem cells (Dayton, Ohio) 36 (11) (2018)

Jian-Xiang Wang.css-eqlu8i{font-size:small;padding-left:4px;} (Jianxiang Wang, Jiangxiang Wang)

Publication Activity (10 Years)

Top Topics

Top Venues

Jian-Xiang Wang (Jianxiang Wang, Jiangxiang Wang)